Oct 18, 2018
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Item 9 Labs Corp. (INLB) trades on the Other OTC in the Drug Manufacturers - Specialty & Generic industry.
Item 9 Labs Corp. company overviewThe latest split shown was on October 18, 2018. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on October 18, 2018.